Today: 19 June 2026

Visa stock slips as activist group presses for an “independent chair” vote

Visa stock slips as activist group presses for an “independent chair” vote

Visa shares fell 0.5% to $350.57 in midday trading Friday as a shareholder group urged support for a proposal to permanently separate the CEO and board chair roles. The vote is set for Visa’s Jan. 27 annual meeting. Mastercard was little changed; American Express slipped 0.8%. Investors are also awaiting Visa’s next earnings update.
9 January 2026
Why Opendoor stock is jumping today: Trump’s $200 billion mortgage-bond buy order

Why Opendoor stock is jumping today: Trump’s $200 billion mortgage-bond buy order

Opendoor shares jumped 20.5% to $7.75 in late morning trading Friday, with volume topping 90 million, after President Trump ordered $200 billion in mortgage-bond purchases. Other housing stocks also rallied. Investors await details on the bond-buying plan and Opendoor’s next earnings report, set for Feb. 26. Vanguard disclosed owning 11.62% of Opendoor as of Dec. 31.
9 January 2026
··
Westlake (WLK) stock steadies near $80 after a 7% jump as analysts reset targets

Westlake (WLK) stock steadies near $80 after a 7% jump as analysts reset targets

Westlake shares rose 0.8% to $80.20 Friday, extending Thursday’s 6.8% surge after the company closed its purchase of ACI/Perplastic’s compounding businesses. Mizuho raised its price target to $88, while BofA cut its target to $82 but kept a buy rating. The stock traded between $78.49 and $81.19. Investors are awaiting late-February earnings for signals on 2026 demand and pricing.
9 January 2026
·
Merck (MRK) stock today: $32 billion Revolution talks and CDC vaccine shift put Feb. 3 in play

Merck (MRK) stock today: $32 billion Revolution talks and CDC vaccine shift put Feb. 3 in play

Merck shares rose 0.4% to $111.41 Friday after a report said it is in talks to buy Revolution Medicines for $28–32 billion. Revolution shares jumped 16% in extended trading. Merck just completed a $221.50-per-share tender offer for Cidara Therapeutics and said the deal will raise 2026 R&D expense by $9 billion. Analysts warned U.S. vaccine policy changes could cut Merck revenue by $2 billion annually.
9 January 2026
···
Robinhood stock edges higher after Argus starts coverage; CEO share sale filing hangs over

Robinhood stock edges higher after Argus starts coverage; CEO share sale filing hangs over

Robinhood shares rose 0.6% to $116.10 Friday after Argus began coverage with a buy rating and $145 price target. CEO Vladimir Tenev sold 375,000 shares this week for about $45.6 million under a prearranged plan, according to a regulatory filing. Barclays trimmed its target to $159 but kept an “overweight” call. A legal brief from Native American groups targeted Robinhood’s prediction market business.
9 January 2026
·
Figure Technology Solutions stock slips after a $62 target hike — what traders watch nextFigureFigure Technology Solutions stock slips after a $62 target hike — what traders watch next

Figure Technology Solutions stock slips after a $62 target hike — what traders watch nextFigureFigure Technology Solutions stock slips after a $62 target hike — what traders watch next

Figure Technology Solutions shares fell 1.5% to $57.50 Friday, easing after a recent price target hike from Keefe, Bruyette & Woods. The stock is up 43% year-to-date and is set to report earnings Feb. 12, with analysts expecting 16 cents per share. FIGR last posted 34 cents per share on $156.37 million revenue in November. Broader fintech and crypto stocks traded mixed.
9 January 2026
·
Exxon Mobil (XOM) stock ticks up as filing flags up to $1.2 bln Q4 upstream hit

Exxon Mobil (XOM) stock ticks up as filing flags up to $1.2 bln Q4 upstream hit

Exxon Mobil shares rose 0.6% to $123.63 after warning lower crude prices may cut Q4 upstream earnings by $800 million to $1.2 billion, partly offset by stronger refining margins. Chevron gained 1.4% as oil prices climbed on supply concerns. Exxon also signed a memorandum with Turkey’s TPAO for exploration in the Black Sea and Mediterranean. Investors await Exxon’s Q4 results on Jan. 30.
9 January 2026
···
CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

CG Oncology shares surged 25.1% to $52.45 after the company advanced the expected release of late-stage bladder cancer trial results to the first half of 2026. The PIVOT-006 Phase 3 trial enrolled over 360 patients and compares cretostimogene grenadenorepvec to surveillance after tumor removal. Trading volume topped 4.1 million shares by midday. Morgan Stanley raised its price target on the stock to $89.
9 January 2026
···
Rocket Lab stock jumps today despite $103 million CFO sale filing: what RKLB traders watch next

Rocket Lab stock jumps today despite $103 million CFO sale filing: what RKLB traders watch next

Rocket Lab shares climbed 4.6% to $86.87 Friday morning after SEC filings showed CFO Adam Spice sold $103.1 million in stock and COO Frank Klein sold $7.3 million, both under preset 10b5-1 plans. Shares had dropped 1.2% Thursday following the insider sales. Investors are watching for the next earnings update and any changes to the Neutron rocket timetable.
9 January 2026
··
Bloom Energy stock jumps again as $2.65B AEP fuel-cell order keeps Wyoming data-center trade in focus

Bloom Energy stock jumps again as $2.65B AEP fuel-cell order keeps Wyoming data-center trade in focus

Bloom Energy shares rose 3.6% to $126.23 Friday after American Electric Power disclosed a $2.65 billion fuel-cell purchase agreement and 20-year offtake deal for a Wyoming facility. Laramie County approved a massive AI data center and 2.7 GW power buildout using Bloom’s fuel cells. Tallgrass estimates the energy infrastructure alone at $7 billion, with total project costs potentially reaching $50 billion.
9 January 2026
·····
Mohawk Industries stock jumps again as housing-rate bets return after Trump mortgage-bond plan

Mohawk Industries stock jumps again as housing-rate bets return after Trump mortgage-bond plan

Mohawk Industries shares climbed about 3% to $117.70 in late morning Friday trading after a 6.9% surge Thursday, topping the 200-day moving average. Wolfe Research downgraded the stock to “Peer Perform,” citing weak prospects for a renovation rebound in early 2026. Traders are watching interest rates and the $114 price level. U.S. job growth slowed in December, with unemployment at 4.4%.
9 January 2026
···
Lockheed Martin stock jumps on Trump defense budget boost, but buyback curbs hang over LMT

Lockheed Martin stock jumps on Trump defense budget boost, but buyback curbs hang over LMT

Lockheed Martin shares rose 4.5% to $541.92 in late morning trading Friday after Trump signed an executive order tying defense contractor payouts to delivery schedules and proposed a $1.5 trillion fiscal 2027 defense budget. Lockheed secured a $22.6 million contract modification for AN/SLQ-32(V)6 work and a C-130 logistics contract. Northrop Grumman and L3Harris also gained.
9 January 2026
··
Why Texas Pacific Land (TPL) stock is up today: oil climbs, insider filings add color

Why Texas Pacific Land (TPL) stock is up today: oil climbs, insider filings add color

Texas Pacific Land shares rose 1.5% to $307.38 in late morning trading Friday, extending a rebound after a 7.7% surge Thursday. The stock moved between $303.83 and $309.79 as oil prices climbed for a second day. Directors Donna E. Epps and Donald G. Cook each received 554 shares as part of board retainers, recent SEC filings show. U.S. payrolls rose by 50,000 in December and unemployment fell to 4.4%.
9 January 2026
··
1 … 935 936 937 938 939 … 2,083

Stock Market Today

  • CareTrust REIT (CTRE) Reports Robust EPS and Revenue Growth, Nears Technical Breakout
    June 19, 2026, 9:16 AM EDT. CareTrust REIT Inc (NYSE:CTRE), a healthcare Real Estate Investment Trust (REIT), posted 63% earnings per share (EPS) growth and 58% revenue growth, signaling strong financial performance. The company also earned a technical setup rating of 7 out of 10 by ChartMill, indicating a favorable position near support levels that could lead to a potential breakout. These metrics highlight CareTrust's expanding footprint in the healthcare property sector amid improving market conditions.

Latest articles

Rocket Lab Drops Even After Nasdaq-100 Nod, SpaceX IPO Buzz Fades

Rocket Lab holds ground ahead of Nasdaq-100 debut after selloff led by SpaceX

19 June 2026
Rocket Lab enters the Nasdaq-100 before Monday’s open, positioning shares for potential index-driven demand after closing at $107.24 Thursday, up 4.7% for the week despite sector volatility and a SpaceX-driven shakeout; KeyBanc upgraded the stock to Overweight with a $135 target, citing strong revenue growth and a $2.2 billion backlog as the company faces a key test with its Neutron rocket still in development.
VW Shares Drop as Dividend Date Passes, Blume Steps Up Cost Cuts

VW Shares Drop as Dividend Date Passes, Blume Steps Up Cost Cuts

19 June 2026
Volkswagen preferred shares dropped 4.24% to €80.53 after trading ex-dividend, as investors weighed a €5.26 payout and CEO Oliver Blume’s warning that the next years are “critical” for cost cuts, capacity reductions, and returns, with 50,000 job cuts planned and over €6 billion in annual savings targeted by 2030.
ASML drops after China chip-tool issue interrupts AI rally

ASML drops after China chip-tool issue interrupts AI rally

19 June 2026
ASML shares fell 0.6% in Amsterdam after the company denied shipping extreme ultraviolet chipmaking machines or parts to China, following a Bloomberg report on U.S. export-control concerns, interrupting an AI-driven rally; China accounted for 33% of ASML sales in 2025, with the company expecting that share to drop to 20% this year amid ongoing policy risks.
Go toTop